Revance Therapeutics, Inc. (NASDAQ:RVNC) Q3 2021 Earnings Conference Call November 9, 2021 4:30 PM ET Company Participants Jessica Serra - IR Mark Foley - CEO Dustin Sjuts - President Toby Schilke - CFO Roman Rubio - SVP, Clinical Development Conference Call Participants Ken Cacciatore - Cowen and Company David Amsellem - Piper Sandler Seamus Fernandez - Guggenheim Nick Rubino - Stifel Vamil Divan - Mizuho Tim Lugo - William Blair Operator Welcome to Revance Therapeutics Third Quarter 2021 Financial Results ...